HRT
Get informed when a big investor buys or sells
+ FollowOvervalued by 79.1% based on the discounted cash flow analysis.
| Market cap | $967.19 Million |
|---|---|
| Enterprise Value | $1.65 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.16 |
| Beta | 0.78 |
| Outstanding Shares | 67,351,727 |
| P/E Ratio | -90.6 |
|---|---|
| PEG | 164.05 |
| Price to Sales | 1.44 |
| Price to Book Ratio | 2.39 |
| Enterprise Value to Revenue | 2.29 |
| Enterprise Value to EBIT | 23.52 |
| Enterprise Value to Net Income | -229 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 1.68 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data